Laidlaw Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-575
| Closed | -$232K | – | 161 |
|
|
2024
Q4 | $232K | Sell |
575
-128
| -18% | -$51.5K | 0.1% | 156 |
|
|
2024
Q3 | $327K | Hold |
703
| – | – | 0.16% | 125 |
|
|
2024
Q2 | $330K | Hold |
703
| – | – | 0.18% | 124 |
|
|
2024
Q1 | $294K | Sell |
703
-523
| -43% | -$219K | 0.16% | 142 |
|
|
2023
Q4 | $499K | Buy |
+1,226
| New | +$499K | 0.18% | 127 |
|
|
2023
Q3 | – | Sell |
-1,072
| Closed | -$377K | – | 373 |
|
|
2023
Q2 | $377K | Buy |
1,072
+37
| +4% | +$13K | 0.07% | 229 |
|
|
2023
Q1 | $326K | Sell |
1,035
-40
| -4% | -$12.6K | 0.07% | 249 |
|
|
2022
Q4 | $310K | Buy |
1,075
+127
| +13% | +$36.7K | 0.07% | 265 |
|
|
2022
Q3 | $274K | Buy |
948
+214
| +29% | +$61.9K | 0.06% | 255 |
|
|
2022
Q2 | $207K | Sell |
734
-140
| -16% | -$39.5K | 0.04% | 341 |
|
|
2022
Q1 | $228K | Buy |
+874
| New | +$228K | 0.04% | 349 |
|